Blood Cancer
Showing 33–48 of 49 results
-
REVLIMID [lenalidomide] capsules, for oral use. Initial US Approval: 2005
Read more -
REZUROCK (belumosudil) tablets, for oral use. Initial U.S. Approval: 2021. Get Access In India
Read more -
RYLAZE (asparaginase erwinia chrysanthemi (recombinant) rywn) injection
Read more -
SCEMBLIX (asciminib) tablets
Read more -
TAFINLAR (dabrafenib) capsules, for oral use. Initial U.S. Approval: 2013
Read more -
Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007
Read more -
TAVALISSE (fostamatinib disodium hexahydrate) tablets, for oral use Initial U.S. Approval: 2018
Read more -
TECVAYLI (teclistamab-cqyv) injection
Read more -
TIBSOVO (ivosidenib tablets), for oral use. Initial U.S. Approval: 2018
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
VYXEOS (daunorubicin and cytarabine) liposome for injection
Read more -
XALKORI (crizotinib) capsules
Read more -
XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
YERVOY (ipilimumab) injection, for intravenous use. Initial U.S. Approval: 2011
Read more -
ZELBORAF (vemurafenib) tablet. FDA-Approved
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more